Cart
sales@molnova.com
Hydroxyzine Pamoate
CAS No. 10246-75-0
Hydroxyzine Pamoate( Hydroxyzine pamoate )
Catalog No. M10113 CAS No. 10246-75-0
Hydroxyzine pamoate is a histamine H1-receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 38 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 96 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 237 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxyzine Pamoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyzine pamoate is a histamine H1-receptor antagonist.
-
DescriptionHydroxyzine pamoate is a histamine H1-receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsHydroxyzine pamoate
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number10246-75-0
-
Formula Weight763.27
-
Molecular FormulaC44H43ClN2O8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESClC1=CC=C(C(N2CCN(CCOCCO)CC2)C3=CC=CC=C3)C=C1.O=C(C4=C(O)C(CC5=C6C=CC=CC6=CC(C(O)=O)=C5O)=C7C=CC=CC7=C4)O
-
Chemical NameEthanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Spahr L, et al. Am J Gastroenterol. 2007 Apr;102(4):744-53.
molnova catalog
related products
-
Metiamide
Metiamide is a histamine H2-receptor antagonist .
-
Dimaprit dihydrochlo...
Dimaprit dihydrochloride is a selective histamine H2 receptor agonist. Dimaprit dihydrochloride also inhibits nNOS with an IC50 of 49 μM. It can stimulate gastric acid secretion.
-
Clobenpropit dihydro...
Clobenpropit dihydrobromide is a potent ?antagonist and inverse agonist of histamine H3R (histamine H3LR,pEC50 of 8.07)Clobenpropit inhibited cell migration and increased apoptosis of pancreatic cancer cells in combination with gemcitabine.?
